| Ticker |
RGC
|
| CIK | 0001829667 |
| SIC | 2833 |
| Sector | Manufacturing |
| Industry Category | Pharmaceutical Products |
| Industry Group | Medicinal Chemicals |
| Address | 11/F FIRST COMMERCIAL BUILDING, 33-35 LEIGHTON ROAD, CAUSEWAY BAY, HONG KONG, K3, 999077 |
| Website | regencellbioscience.com |
| Phone | 852 2155 0823 |
| CEO | Yat-Gai Au |
| Employees | 10 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Regencell Bioscience (RGC) Nosedives 19.8% on Profit-TakingRegencell Bioscience Holdings Ltd. (NASDAQ:RGC) is one of the 10 Stocks Crash Hard Alongside Wall Street. Regencell Bioscience fell by 19.83 percent on Monday to close at $18.43 apiece as investors appeared to have taken profits following Friday’s 122-percent surge. Monday’s drop, however, was primarily due to the lack of catalysts to support investing appetite, with […] Regencell Bioscience Stock Volatility Continues MondayThe roller-coaster ride for Regencell Bioscience Holdings shares continued Monday. Regencell's 82,000% Surge: The $33 Billion Stock Rally That Nobody Can ExplainA biotech mystery with no profits, no news, and a crash that left billions in paper wealth erased Mystery $33 Billion Medicine Fortune Collapses in Days(Bloomberg) -- When Yat-Gai Au was worth $33 billion on paper, he wasn’t in his Hong Kong office.Most Read from BloombergPhiladelphia Transit System Votes to Cut Service by 45%, Hike FaresUS Renters Face Storm of Rising CostsSqueezed by Crowds, the Roads of Central Park Are Being ReimaginedMapping the Architectural History of New York’s ChinatownUS State Budget Wounds Intensify From Trump, DOGE Policy ShiftsOne week later, when his net worth plunged to $10.1 billion, he wasn’t around either.Offi Regencell Bioscience Holdings (NasdaqCM:RGC) Announces 38:1 Stock Split Effective June 2025Regencell Bioscience Holdings (NasdaqCM:RGC) recently announced a significant 38:1 stock split with an additional stock dividend, effective June 16, 2025. This announcement has played a key role in the company's extraordinary share price increase of approximately 4006% over the past quarter. While the broader market faced fluctuations due to geopolitical tensions, particularly with oil prices reacting to Middle East conflicts, Regencell's impressive rise contrasts sharply with these events... |
